Delivery Order SPE2DB20D6035-SPE2DB25FLYHY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $1,309.08. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $5,667.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trintellix 5 mg tablets (30-count units) on June 12, 2025, with an ultimate completion date of June 13, 2025. The contract was not set-aside and represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will occur at the vendor's corporate office location in Conshohocken, PA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trintellix 10 mg tablets in a 30-count package, with a ceiling value of $1,538.48. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 16, 2025. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Trintellix 5 mg tablets (30-count unit) valued at $1,263.99. This firm fixed-price delivery order, which matures on June 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trintellix 10 mg tablets (30-count) under a firm fixed-price contract valued at $4,781.16. This is a non-set-aside competitive award with an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,955.35 on August 4, 2025, for the supply of Trintellix 20 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- This delivery order, awarded September 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Trintellix 20 mg tablets (30-count) with a firm fixed price ceiling value of $1,697.73 and an ultimate completion date of September 5, 2025. The award is issued under a non-set-aside competitive procurement and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,878.66 to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The order represents a small-value transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,392.88 to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. The pharmaceutical will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Trintellix 5 mg tablets (30-count packages) valued at $3,315.85. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract reflects AmerisourceBergen's role as a critical pharmaceutical supplier to the federal medical procurement system, particularly for military and veteran healthcare needs. Performance...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYHYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,016.30 to AmerisourceBergen Drug Corp for the supply of Trintellix 5 mg tablets (30-count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Trintellix (vortioxetine) is a prescription antidepressant used in the treatment of major depressive disorder, and this particular delivery order fulfills a specific medical supply requirement within the broader DLA pharmaceutical procurement program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/23/25 |